Suchergebnisse - "Breccia, Massimo"

PubPharm (960)

91

Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib : The multicentre retrospective RUX-IOL study

enthalten in: British journal of haematology | 2022

von Elli, E. | Di Veroli, A. | Bartoletti, D. | +27

92

Chronic Myeloid Leukemia Data at ASH 2021 : A Podcast on Patient Unmet Needs and Later-Line Treatment Developments

enthalten in: Advances in therapy | 2022

von Breccia, M.

93

Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group

enthalten in: Annals of hematology | 2022

von Pepe, S. | Rossi, E. | Trawinska, M. | +12

94

Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group

enthalten in: Annals of hematology | 2022

von Pepe, S. | Rossi, E. | Trawinska, M. | +12

95

Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group

enthalten in: Annals of hematology | 2022

von Pepe, S. | Rossi, E. | Trawinska, M. | +12

96

COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report

enthalten in: British journal of haematology | 2022

von Breccia, M. | Abruzzese, E. | Accurso, V. | +46

CommentIn: Br J Haematol. 2022 Feb;196(3):471-472. - PMID 34708401

97

Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments

enthalten in: Advances in therapy | 2022

von Breccia, M.

98

Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments

enthalten in: Advances in therapy | 2022

von Breccia, M.

99

Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments

enthalten in: Advances in therapy | 2022

von Breccia, M.

100

Utility of procalcitonin and C-reactive protein as predictors of Gram-negative bacteremia in febrile hematological outpatients

enthalten in: Supportive care in cancer | 2022

von Jabbour, J. | Ciotti, G. | Maestrini, G. | +13